Therefore, the sustained TβRI expression potentially mediated by PARP inhibition on intra-tumor T cells can contribute to increase the differentiation rate toward a CD103+ phenotype, distinctive of Tres, thus indirectly promoting higher intra-tumor T cell infiltration and better anti-tumor effector function. Here, PARP1 is linked to neoplasm.